Skip to main content

Hyperfine, Inc.

HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001833769

In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Hyperfine, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of HYPR: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders7377+4
Shares16.6M18.0M+1.33M (+8.0%)
Value$166.3M$177.0M+$10.7M (+6.4%)

New holders (7)

Institutions that held Hyperfine, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to HYPR in Q2 2021
InstitutionSharesValue% of portfolio
Empyrean Capital Partners, LP199,951$1.97M0.05%
Picton Mahoney Asset Management128,309$1.26M0.05%
RP Investment Advisors LP114,662$1.13M0.15%
Silphium Asset Management Ltd100,000$985.0K0.39%
Geode Capital Management, LLC11,300$111.0K0.00%
Quadrant Private Wealth Management, LLC10,146$100.0K0.04%
Wolverine Asset Management LLC8,975$88.0K0.00%

Sold out (3)

Institutions that held Hyperfine, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of HYPR in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Linden Advisors LP38,994$389.0K
Arrowstreet Capital, Limited Partnership17,940$179.0K
DeepCurrents Investment Group LLC10,000$100.0K